Nathalie Adda
- Hepatology top 0.5%
- Epidemiology top 1%
- Infectious Diseases top 2%
- Rheumatology top 5%
- Molecular Biology
- Co-authors
- Robert S. KauffmanShelley GeorgeNezam H. AfdhalHendrik W. ReesinkIra M. JacobsonKenneth E. ShermanStefan ZeuzemMark Sulkowski
- Topics
- Hepatitis C virus research (29 papers)HIV/AIDS drug development and treatment (20 papers)Liver Disease Diagnosis and Treatment (16 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Nathalie Adda
54 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Hepatology 2.0k
- Epidemiology 1.8k
- Infectious Diseases 685
- Rheumatology 181
- Molecular Biology 133
Countries citing papers authored by Nathalie Adda
This map shows the geographic impact of Nathalie Adda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie Adda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie Adda more than expected).
Fields of papers citing papers by Nathalie Adda
This network shows the impact of papers produced by Nathalie Adda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie Adda. The network helps show where Nathalie Adda may publish in the future.
Co-authorship network of co-authors of Nathalie Adda
This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie Adda. A scholar is included among the top collaborators of Nathalie Adda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie Adda. Nathalie Adda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 87 | |
| 2 | 66 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 114 | |
| 6 | 1 | |
| 7 | 35 | |
| 8 | 74 | |
| 9 | 8 | |
| 10 | 11 | |
| 11 | 48 | |
| 12 | 1 | |
| 13 | Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infectionbreakdown → | 566 |
| 14 | 26 | |
| 15 | 39 | |
| 16 | 7 | |
| 17 | 8 | |
| 18 | 0 | |
| 19 | 40 | |
| 20 | 4 |
About Nathalie Adda
Nathalie Adda is a scholar working on Hepatology, Infectious Diseases and Rheumatology, having authored 55 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (29 papers), HIV/AIDS drug development and treatment (20 papers) and Liver Disease Diagnosis and Treatment (16 papers). The work is most often cited by research in Hepatology (2.0k citations), Epidemiology (1.8k citations) and Infectious Diseases (685 citations). Nathalie Adda has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Robert S. Kauffman, Shelley George, Nezam H. Afdhal, Hendrik W. Reesink, Ira M. Jacobson, Kenneth E. Sherman, Stefan Zeuzem, Mark Sulkowski, Mohammad Bsharat and Andrew J. Muir. Their work appears in journals such as New England Journal of Medicine, Annals of Internal Medicine and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.